Inari Medical, Inc. (NARI) Misses Q4 EPS by 1c

Go back to Inari Medical, Inc. (NARI) Misses Q4 EPS by 1c

Inari Medical Inc. (NARI) PT Lowered to $108 at Morgan Stanley

February 24, 2022 8:55 AM EST

Morgan Stanley analyst Cecilia Furlong lowered the price target on Inari Medical Inc. (NASDAQ: NARI) to $108.00 (from $119.00) while maintaining a Overweight rating.

... More